about
Decreased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor promotes growth of human breast cancer cellsThe role of endocytic Rab GTPases in regulation of growth factor signaling and the migration and invasion of tumor cellsPrimate mammary gland insulin-like growth factor system: cellular localization and regulation by sex steroids.Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density.Treatment of murine breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor decreases the level of plasminogen activator transcripts, inhibits cell growth in vitro, and reduces tumorigenesis in vivo.CFIm25 links alternative polyadenylation to glioblastoma tumour suppression.Leukocyte DNA as surrogate for the evaluation of imprinted Loci methylation in mammary tissue DNA.Natural product derived receptor tyrosine kinase inhibitors: identification of IGF1R, Tie-2, and VEGFR-3 inhibitors.The insulin-like growth factor I receptor/insulin receptor tyrosine kinase inhibitor PQIP exhibits enhanced antitumor effects in combination with chemotherapy against colorectal cancer models.Lymph node status as a guide to selection of available prognostic markers in breast cancer: the clinical practice of the future?Differential expression of arrestins is a predictor of breast cancer progression and survival.Role of IGF1R in Breast Cancer Subtypes, Stemness, and Lineage DifferentiationInsulin-like growth factor system gene expression in women with type 2 diabetes and breast cancer.Cross-Sectional Associations between Body Size, Circulating Sex-Steroid Hormones and IGF Components among Healthy Chinese Women.Med1 plays a critical role in the development of tamoxifen resistance.Regulation of IMP3 by EGFR signaling and repression by ERβ: implications for triple-negative breast cancer.Interaction between cyclooxygenase-2 and insulin-like growth factor in breast cancer: A new field for prevention and treatmentTargeting the insulin-like growth factor receptor: developing biomarkers from gene expression profiling.Identification of gene sets and pathways associated with lactation performance in mice.Tumor-derived p53 mutants induce oncogenesis by transactivating growth-promoting genes.Low-dose paclitaxel prior to intratumoral dendritic cell vaccine modulates intratumoral cytokine network and lung cancer growth.Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization.Downregulation of the potential suppressor gene IGFBP-rP1 in human breast cancer is associated with inactivation of the retinoblastoma protein, cyclin E overexpression and increased proliferation in estrogen receptor negative tumors.Effect of low dose tamoxifen on the insulin-like growth factor system in healthy women.Marked lymphovascular invasion, progesterone receptor negativity, and high Ki67 labeling index predict poor outcome in breast cancer patients treated with endocrine therapy alone.C-myc gene expression alone is sufficient to confer resistance to antiestrogen in human breast cancer cells.Inhibition of angiogenesis-relevant receptor tyrosine kinases by sulindac analogues.Insulin-like growth factors: actions on the skeleton.A pilot study of recombinant insulin-like growth factor-1 in seven multiple sderosis patients.The Relation of Obesity-Related Hormonal and Cytokine Levels With Multiple Myeloma and Non-Hodgkin Lymphoma.
P2860
Q24798573-617A07CD-0B8E-4075-99E7-E1E4471DFF2DQ26796377-AB072951-5BA8-4B9B-89F2-06C41079C732Q32056605-469DBB5C-66FB-4866-94FE-476FA8177165Q33543396-12361543-2777-44A5-AAC4-11D443376CC3Q33918953-F95CE73C-F381-48B8-BDD5-914C3E5FCEC6Q34027447-D4239A37-6C78-4661-8662-3A98725F655FQ34586415-2B89F3FC-7582-4DF7-A01E-63B35A0074CDQ35030176-1BE41B92-E350-44A0-AB78-A77D7A63FB05Q35058305-3C87AB98-0027-4FDE-B698-A88EC22097ABQ35157568-603B15F4-3B49-44DE-801C-6457FF0542DAQ35166797-EA3EF361-39AD-4634-BBD0-26A421DD2BEEQ35535296-C4F3F717-7F29-4B0D-B93E-00DF20866103Q35586993-F52BA5EA-1BD7-47C4-BC75-EE0B91F7E9A0Q35767673-F2D11453-75A7-4D26-B18D-8032E3660ED7Q35883606-73A89424-E06F-4743-81FF-26F9E62A0EA1Q35916537-FEF1B390-F2A1-41F3-B00F-FE45E9B444D2Q35995604-89DB8385-B28B-4B56-998F-72C3A2441607Q37588787-66000E05-E146-4172-BC9A-156B00B640B9Q38493090-DA24A202-3AE3-44F5-865D-8BED16EA98F6Q40568020-770796FA-81EA-4794-BA43-717FB0A25C62Q40614433-8C599D56-C121-489B-9DED-7DFCFC32A979Q42835415-5CE149E0-1C0F-4D4C-B90F-030A599C607BQ43655914-5B2CEAEC-295C-4DA5-9EA2-C0C9D79142C4Q43835711-3C1C0D06-E0B3-487D-BED1-9C4A79304612Q43935330-09EEF5A1-E147-451D-8E29-6112112AEB42Q43956063-50B7F7FA-4A26-4863-93D2-64957465FBDFQ45254680-8907D4F0-8FB7-4A07-8674-E2B60E84D051Q52329568-B276FCCF-D14D-4CE6-BA21-64DA8C4FE2ADQ54399172-BABF370B-A4AF-4D8B-9E6B-466CC0286B03Q55139939-7BE00FE7-C692-4F9E-B242-240FE6C1BE6F
P2860
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Insulin-like growth factors in human breast cancer.
@ast
Insulin-like growth factors in human breast cancer.
@en
Insulin-like growth factors in human breast cancer.
@nl
type
label
Insulin-like growth factors in human breast cancer.
@ast
Insulin-like growth factors in human breast cancer.
@en
Insulin-like growth factors in human breast cancer.
@nl
prefLabel
Insulin-like growth factors in human breast cancer.
@ast
Insulin-like growth factors in human breast cancer.
@en
Insulin-like growth factors in human breast cancer.
@nl
P2093
P2860
P356
P1476
Insulin-like growth factors in human breast cancer
@en
P2093
M E Redington
P2860
P2888
P304
P356
10.1023/A:1006127621512
P407
P577
1998-01-01T00:00:00Z
P6179
1006665164